Moderna's stock performance draws attention as Jim Cramer analyzes first-quarter market trends. The S&P 500 and Nasdaq 100 show divergent momentum in early 2026.
- Moderna's stock is in focus due to positive commentary from Jim Cramer.
- Cramer reviewed top performers and laggards in major indices for the first quarter.
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article